��ժҪ��Ϣ

[an error occurred while processing this directive]

��Ƥ��Բ�ѧ��־ 2003, 29(3) 161-163 DOI: ISSN: 2096-5540 CN: 32-1880/R

��Ŀ¼ | ��Ŀ¼ | �� | �߼�� [��ӡ��ҳ] [�ر�]

��

	��չ��

	��Ϣ
	Supporting info
	PDFȫ��
	[HTMLȫ��]
	�ο��
	��뷴��
	�ѱ��Ƽ��
	��ҵ��
	��ù��
	��ñ��
	Email Alert
	��·��
	��Ϣ
	��Ĺؼ��
	��
	HLA
	��λ��
	��
	��
	��
	PubMed
	Article by
	Article by

��HLA��λ��о��չ

��, ��

��е��ҽԺƤ��, 310009

ժҪ��

��Ĳ��в��,Ŀǰ�о��Ϊ�䷢��Ŵ��,��и��ӵĶ��Ƶ��ص�,��ϸ��ԭHLA-��ࡢ��༰��ء��,HLA�ڷǢ񡢢��Լ��Ҳ��á�HLA��Ķ�̬�Ծ��HLA��ӵĶ��ԡ��ʶHLA��ˮƽ�Ķ�̬��,��ڰ��Ļ��Ϻ��ơ��˽��ص��о��չ��

�ؼ���� HLA ��λ��

Abstract:

Keywords:

�ո�� 2002-09-09 �޻�� ��淢��

DOI:

��Ŀ:

ͨѶ��:

��߼��:

�ο��ף�

[1] Kemp EH, Waterman EA, Hawes BE, et al. The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo. J Clin Invest, 2002, 109 (7):923-930.
[2] van den Wijngaard R, Wankowicz-Kalinska A, Pals S, et al. Autoimmune melanocyte destruction in vitiligo. Lab Invest, 2001, 81 (8):1061-1067.
[3] Njoo MD, Westerhof W. Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol, 2001, 2(3):167-181.
[4] Kim SM, Chung HS, Hann SK. The genetics of vitiligo in Korean patients. Int J Dermatol, 1998, 37(12):908-910.
[5] Arcos-Burgos M, Parodi E, Salgar M, et al. Vitiligo:complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA. Hum Genet, 2002, 110(4):334-342.
[6] Boisseau-Garsaud AM, Saint-Cyr I, Quist D, et al. Familial aggregation of vitiligo in the French West Indies (Isle of Martinique). Eur J Dermatol, 2001, 11(6):554-556.
[7] Robinson J, Waller MJ, Parham P,et al. IMGT/HLA Database-a sequence database for the human major histocompatibility complex. Nucleic Acids Res, 2001,29(1):210-213.
[8] Little AM, Pasham P. Polymorphism and evolution of HLA class I and �� genes and molecules. Rev Immunogenet, 1999, 1 (1):105-123.
[9] The MHC sequencing consortium. Complete sequence and gene map of a human major histocompatibility complex. Nature, 1999, 401(6756):921-923.
[10] Bue M, Busova B, Hegyi E,et al. Vitiligo is associated with HLA-A2and HLA-Dw7 in the Slovak populations. Folia Biol (Praha), 1996,42(1-2):23-25.
[11] Lorini R, Orecchia G, Martinetti M, et al. Autoimmunity in vitiligo:relationship with HLA, Gm and Km polymorphisms. Autoimmunity,1992, 11 (4):255-260.
[12] Orecchia G, Perfetti L, Malagoli P, et al. Vitiligo is associated with a significant increase in HLA-A30, Cw6 and DQw3 and a decrease in C4AQ0 in northern Italian patients. Dermatology, 1992, 185 (2):123-127.
[13] Ando I, Chi HI, Nakagawa H, et al. Difference in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental type. Br J Dermatol, 1993, 129(4):408-410.
[14] al-Fouzan A, al-Arbash M, Fouad F,et al. Study of HLA class I/IL and T lymphocyte subsets in Kuwaiti vitiligo patients. Eur J Immunogenet, 1995, 22(2):209-213.
[15] Venkataram MN, White AG, Leeny WA,et al. HLA antigens in Omani patients with vitiligo. Clin Exp Dermatol, 1995, 20(1):35-37.
[16] Schallreuter KU, Levenig C, Kuhnl P, et al. Histocompatibility antigens in vitiligo:Hamburg study on 102 patients from northern Germany. Dermatology, 1993, 187 (3):186-192.
[17] Venneker GT, de Waal LP, Westerhof W, et al. HLA associations in vitiligo patients in the Dutch population. Dis Markers, 1993, 11 (4):187-190.
[18] Buc M, Fazekasova H, Cechova E, et al. Occurrence rates of HLADRB1, HLA-DQB1, and HLA-DPB1 alleles in patients suffering from vitiligo. Eur J Dermatol, 1998, 8(1):13-15.
[19] Zamani M, Spaepen M, Sghar SS, et al. Linkage and association of HLA class �� genes with vitiligo in a Dutch population. Br J Dermatol,2001, 145(1):90-94.
[20] Moretti S, Spallanzani A, Amato L, et al. New insights into the pathogenesis of vitiligo:imbalance of epidermal eytokines at sites of lesions.Pigment Cell Res, 2002, 15(2):87-92.

��е��

1��ΰ,��.��[J]. ��Ƥ��Բ�ѧ��־, 2007,33(4): 222-

2��,��ѧ��.��ػ��о��ع�[J]. ��Ƥ��Բ�ѧ��־, 2007,33(4): 219-

3��,��ٺ�,֣־��.308 nm׼��Ӽ��ư��״[J]. ��Ƥ��Բ�ѧ��־, 2006,32(3): 150-

4��.խ��UVB311��UVB��ÿ��ư��[J]. ��Ƥ��Բ�ѧ��־, 2006,32(3): 161-

5��, ��.��[J]. ��Ƥ��Բ�ѧ��־, 2007,33(6): 355-357

6��Ҧ�ܲ�.��±��/��ư��[J]. ��Ƥ��Բ�ѧ��־, 2008,34(2): 77-77

7��,��.��Ƥ��зǺ��ϸ��չ[J]. ��Ƥ��Բ�ѧ��־, 2008,34(3): 178-180

8��,��.��ͯ��ٴ��ѧ�о�[J]. ��Ƥ��Բ�ѧ��־, 2008,34(4): 211-214

9��ѧ��,ξ��,��.��Ƥϸ��Һ��ֲ��ư��Ӱ��[J]. ��Ƥ��Բ�ѧ��־, 2008,34(4): 238-240

10��,ξ��,��.��縺ѹ��Ƥ��ֲ��Ӱ��[J]. ��Ƥ��Բ�ѧ��־, 2008,34(5): 305-307

11��zhuwu,��.��综�ߵ��ط��[J]. ��Ƥ��Բ�ѧ��־, 2008,34(5): 338-339